Tag Archives: OGN stock research

Organon (OGN) 24Q4 Update

24Q4 revenues were $1.59 billion, up 3% at constant currency but down 0.4% YOY and 2.8% below my estimate.  GAAP diluted EPS was $0.42, compared with 23Q4’s $2.13 and my estimate of $0.60.  Non-GAAP EPS of $0.90 was above last … Continue reading

Posted in Health Care, OGN | Tagged , | Leave a comment